High-yield dividend stocks may not appeal to some investors. However, if you're among those investors looking for income, ...

Investors who own ABBV stock may stay invested as the company has faced its biggest challenge quite well and looks set to return to robust growth next year.

and migraine drugs Ubrelvy (ubrogepant) and Qulipta (atogepant). The boards of both AbbVie and Cerevel have approved the transaction, which is expected to close in the middle of 2024, subject to ...

The company raised its full-year revenue and EPS guidance, reflecting robust performance across key products like Venclexta, Vraylar, Ubrelvy, and Qulipta. AbbVie also completed the acquisition of ...

Strong sales performance of drugs like Rinvoq, Skyrizi, Venclexta and Vraylar, coupled with significant contributions from newer drugs like Ubrelvy, Elahere, Epkinly and Qulipta, should keep ...

Cambia (diclofenac potassium) may not be safe to take while pregnant or breastfeeding. Certain factors, including the risks of not treating your condition during pregnancy and fetal harm, may ...

We recently compiled a list of the 13 Best Pharma Dividend Stocks To Buy In 2024. In this article, we are going to take a look at where AbbVie Inc. (NYSE:ABBV) stands against the other pharma ...

Ajovy ( fremanezumab-vfrm) is a prescription drug that’s used to prevent migraine episodes in adults. Ajovy comes as a single-use prefilled syringe or pen that you inject under your skin. Ajovy ...

After hours: 7:59:44 pm GMT-5 ...

Pre-Market: 8:29:06 a.m. EST ...